Increase Tresiba by 10-20% (4-7 units) immediately and titrate every 3 days until fasting glucose reaches target
With fasting blood sugars in the 200s on 36 units of Tresiba, you need to uptitrate the basal insulin dose aggressively using a structured algorithm. The most recent ADA/EASD 2023 guidelines provide clear titration protocols for this exact scenario 1, 2.
Immediate Titration Strategy
For fasting blood glucose >180 mg/dL, increase the total daily dose by 20% (approximately 7 units), bringing the dose to 43 units 1. Alternatively, using the more conservative approach: add 2 units every 3 days until fasting glucose targets are met 2. Given the severity of hyperglycemia (200s), the more aggressive 20% increase is justified.
The FDA label for Tresiba confirms that dose adjustments should occur every 3-4 days, with longer-acting basal insulins like degludec requiring slower titration due to longer time to steady state 3.
Structured Titration Algorithm
Follow this evidence-based approach 1, 2:
- FBG >180 mg/dL: Add 20% of current dose (7 units → new dose 43 units)
- FBG 140-180 mg/dL: Add 10% of current dose (4 units → new dose 40 units)
- FBG 110-139 mg/dL: Add 1 unit
Reassess every 3 days and continue adjusting until fasting glucose reaches individualized target (typically <110-130 mg/dL) 2.
Critical Considerations Before Intensification
Before simply increasing basal insulin, evaluate for "overbasalization" 2. Key signals include:
- Large bedtime-to-morning glucose differential
- Elevated postprandial-to-preprandial differentials
- Basal dose >0.5 units/kg/day (approximately >40-50 units for average adult)
If the patient weighs approximately 72 kg, the current 36 units represents 0.5 units/kg—approaching the threshold where prandial coverage becomes necessary 1, 4, 5.
When Basal Insulin Alone Is Insufficient
If fasting glucose normalizes but A1C remains elevated, or if basal doses exceed 0.5 units/kg/day, add prandial insulin or a GLP-1 receptor agonist 1, 2, 5. The 2023 AACE guidelines emphasize considering fixed-ratio combinations (basal insulin/GLP-1 RA) before advancing to full basal-bolus regimens 1.
For prandial insulin initiation:
- Start with 4 units or 10% of basal dose before the largest meal 2
- Consider reducing basal dose by same amount if A1C <8% 2
- Progress stepwise to 2-3 meals if needed
Hypoglycemia Risk Mitigation
Tresiba's ultra-long duration of action (>42 hours) provides more stable glucose-lowering with lower nocturnal hypoglycemia risk compared to other basal insulins 6, 7. However, intensify glucose monitoring during titration 3.
If hypoglycemia occurs (BG <70 mg/dL), reduce dose by 10-20% 1, 2. For BG <40 mg/dL, reduce by 20-40% 1.
Practical Implementation
- Tresiba can be dosed at any time of day in adults (unlike pediatric patients who require same-time dosing) 3
- Ensure at least 8 hours between doses if a dose is missed 3
- Continue metformin and consider adding/continuing GLP-1 RA or SGLT2i for cardiorenal protection 1, 5
- Discontinue sulfonylureas to reduce hypoglycemia risk once insulin is optimized 5
Common Pitfall
The most critical error is therapeutic inertia—failing to uptitrate promptly when glucose remains elevated 1, 2. Blood sugars in the 200s represent significant hyperglycemia requiring immediate action, not gradual 1-2 unit adjustments over weeks.